USNA Stock Recent News

USANA Health Sciences' pivot from MLM to omnichannel, highlighted by the Hiya Health acquisition, marks a strategic inflection point for renewed growth and relevance. The company's scientific credibility, strong balance sheet, and global reach position it well, despite recent revenue declines and heavy China exposure. Valuation is attractive at 12× forward earnings and 5× EBITDA, with catalysts including Hiya's growth, margin expansion, and potential buybacks.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2025 results will be released after the close of market on Tuesday, July 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instit.

SALT LAKE CITY , July 2, 2025 /PRNewswire/ -- With freedom as a universal desire being celebrated this month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals and families to celebrate freedom on a personal level for self-care. Research reveals countless global celebrations honoring freedom—from America's Independence Day on July 4 to the unifying spirit of Canada Day on July 1 and numerous others around the world.

Enhanced incentives, a renewed brand story, and stronger sales system are aimed at driving early success and sustainable growth for USANA Brand Partners SALT LAKE CITY , July 1, 2025 /PRNewswire/ -- USANA, a global leader in cellular nutrition, announced an elevated opportunity to its global Brand Partners this week, including an updated brand story and enhanced compensation plan. The updated incentives fully launch in October and give USANA Brand Partners improved tools for attracting and retaining new customers and team members.

Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?

USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.

SALT LAKE CITY , June 17, 2025 /PRNewswire/ -- USANA President and CEO Jim Brown has been elected to the Board of Directors of the Direct Selling Association (DSA), a national trade organization for direct sales companies. Mr. Brown was elected by members of the Association and will serve a three-year term.

Company recognized for its CellSentials supplement, Celavive skincare line, research and development, and USANA Foundation SALT LAKE CITY , June 12, 2025 /PRNewswire/ -- USANA, a leader in global nutrition, was recently honored by the Best of State awards in Salt Lake City, Utah, for its excellence in product quality, innovation, and charitable contributions. USANA took home four Best of State medals along with the highly sought-after Best of State Statue (The BOSS®) in the following categories: Science & Technology Overall—USANA's submission for its Research and Development team earned the company its fifth BOSS award since 2008 and first since 2016 Dietary Supplement—USANA CellSentials took home this honor for the ninth consecutive year Personal Care Products—USANA's Celavive skincare won for the eighth consecutive year Private Sector Community Development—The USANA Foundation won its first Best of State award Research and Development—USANA's R&D team won for the seven